Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7787]

$ASH 2013: Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma with autologous T cells genetically-engineered to express an anti-CD19 chimeric antigen receptor$

ASH 2013: Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma with autologous T cells...

$ASH 2013: Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies following T cell immunotherapy$

ASH 2013: Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell...

FDA approves new drug for advanced prostate cancer

FDA approves new drug for advanced prostate cancer

Regulatory approval for biosimilar trastuzumab for treating breast cancer

Regulatory approval for biosimilar trastuzumab for treating breast cancer

FDA approves the use of sorafenib for thyroid carcinoma

FDA approves the use of sorafenib for thyroid carcinoma

Insight into melanoma drug resistance pathways identifies potential new treatment option

Insight into melanoma drug resistance pathways identifies potential new treatment option

Studies identify cell-signaling pathway alterations responsible for melanoma drug resistance

Studies identify cell-signaling pathway alterations responsible for melanoma drug resistance

Pill gives new hope to melanoma patients whose skin cancer has spread to the brain

Pill gives new hope to melanoma patients whose skin cancer has spread to the brain

European Commission grants marketing authorization for radium-223 chloride

European Commission grants marketing authorization for radium-223 chloride

FDA gives accelerated approval to ibrutinib for mantle cell lymphoma

FDA gives accelerated approval to ibrutinib for mantle cell lymphoma

More from ecancer